91st General Assembly
Status of HB2256
   [ Home ]   [ Back ]   [ Legislation ]
Legislation:  
Please enter a bill number.



 Full Text  Bill Summary
O'BRIEN-HASSERT-BURKE-LOPEZ-HAMOS, LYONS,JOSEPH, 
   CURRY,JULIE, CROTTY, FOWLER, PERSICO, HOFFMAN, WAIT, 
   BRADLEY, DAVIS,MONIQUE, HARRIS AND MCGUIRE.

(SYVERSON-MAHAR-FAWELL-SHADID-MUNOZ)

   225 ILCS 85/25            from Ch. 111, par. 4145                           
   410 ILCS 620/3.14         from Ch. 56 1/2, par. 503.14                      

        Amends the Pharmacy Practice Act and the Illinois Food, Drug  and      
   Cosmetic  Act.  Provides that pharmacists may substitute generic brand      
   drugs, provided that the selected drug has been rated  therapeutically      
   equivalent  to  the  prescribed drug in the Orange book or meets other      
   criteria. Effective immediately.                                            
        HOUSE AMENDMENT NO. 1.                                                 
        Deletes a provision in the Illinois Food, Drug and  Cosmetic  Act      
   that  provides  that  the determination of drug products that have not      
   been rated therapeutically equivalent in the Orange book, but that may      
   be selected shall be recommended by a Technical  Advisory  Council  of      
   the Department.                                                             
          BALANCED BUDGET NOTE, H-AM 1 (Bureau of the Budget)                  
          Since this bill is not a supplemental appropriation bill,            
          the Balanced Budget Note Act is inapplicable.                        
          JUDICIAL NOTE, H-AM 1 (Administrative Office of Ill. Courts)         
          There would be neither a decrease nor an increase in the number      
          of judges needed.                                                    
        GOVERNOR'S AMENDATORY VETO MESSAGE                                     
        Recommends changing the bill to provide that the therapeutically       
   equivalent generic brand that the pharmacist may substitute for name        
   brands may not be a critical dose drug and that the Technical Advisory      
   Council be allowed to consider drugs that require a prescription and        
   are legally marketed in the United States according to FDA regula-          
   tions. Recommends a definition for "critical dose drug".                    
   99-02-19  H  FIRST READING                                                  
   99-02-19  H  ADDED AS A JOINT SPONSOR                 HASSERT               
   99-02-19  H  ADDED AS A JOINT SPONSOR                 BURKE                 
   99-02-19  H  ADDED AS A JOINT SPONSOR                 LOPEZ                 
   99-02-19  H  ADDED AS A JOINT SPONSOR                 HAMOS                 
   99-02-19  H  REFERRED TO HOUSE RULES COMMITTEE        RULES                 
   99-02-24  H       ASSIGNED TO COMMITTEE               EXECUTIVE             
   99-03-03  H                     FISCAL NOTE REQUESTED POE                   
   99-03-03  H  STATE MANDATES FISCAL NOTE REQUESTED     POE                   
   99-03-03  H  BALANCED BUDGET NOTE REQUESTED           POE                   
   99-03-03  H  HOME RULE NOTE REQUESTED                 POE                   
   99-03-03  H                   JUDICIAL NOTE REQUESTED POE                   
   99-03-03  H                             AMENDMENT NO. 01-EXECUTIVE     H    
   99-03-03  H                                   ADOPTED                       
   99-03-03  H  DO PASS AMENDED/SHORT DEBATE             015-000-000   HEXC    
   99-03-03  H  PLACED CALENDAR 2ND READING-SHORT DEBATE                       
   99-03-04  H  ADDED AS A CO-SPONSOR                    LYONS,JOSEPH          
   99-03-05  H  ADDED AS A CO-SPONSOR                    MCCARTHY              
   99-03-05  H  ADDED AS A CO-SPONSOR                    CURRY,JULIE           
   99-03-05  H  ADDED AS A CO-SPONSOR                    CROTTY                
   99-03-05  H  ADDED AS A CO-SPONSOR                    FOWLER                
   99-03-09  H  BALANCED BUDGET NOTE FILED AS AMENDED    BY HOUSE AMEND #1     
   99-03-09  H             FISCAL NOTE REQUEST-WITHDRAWN POE                   
   99-03-09  H  STATE MANDATES FISCAL NOTE REQST-WITHDRN POE                   
   99-03-09  H  BALANCED BUDGET NOTE REQUEST-WITHDRAWN   POE                   
   99-03-09  H  HOME RULE NOTE REQUEST-WITHDRAWN         POE                   
   99-03-09  H  JUDICIAL NOTE REQUEST-WITHDRAWN          POE                   
   99-03-09  H  SECOND READING-SHORT DEBATE                                    
   99-03-09  H  PLCD CAL ORDER 3RD READING-SHORT DEBATE                        
   99-03-10  H  ADDED AS A CO-SPONSOR                    PERSICO               
   99-03-10  H  ADDED AS A CO-SPONSOR                    HOFFMAN               
   99-03-10  H  JUDICIAL NOTE FILED AS AMENDED           BY HOUSE AMEND #1     
   99-03-10  H  CALENDAR ORDER 3RD READING-SHORT DEBATE                        
   99-03-11  H  THIRD READING/SHORT DEBATE/PASSED        107-008-001           
   99-03-12  H  ADDED AS A CO-SPONSOR                    WAIT                  
   99-03-12  H  ADDED AS A CO-SPONSOR                    GRANBERG              
   99-03-12  H  ADDED AS A CO-SPONSOR                    BRADLEY               
   99-03-12  H  ADDED AS A CO-SPONSOR                    DAVIS,MONIQUE         
   99-03-12  H  ADDED AS A CO-SPONSOR                    HARRIS                
   99-03-12  H  ADDED AS A CO-SPONSOR                    MCGUIRE               
   99-03-16  S  ARRIVE IN SENATE                                               
   99-03-16  S  CHIEF SPONSOR                            SYVERSON              
   99-03-16  S  ADDED AS A CHIEF CO-SPONSOR              MAHAR                 
   99-03-16  S  ADDED AS A CHIEF CO-SPONSOR              KARPIEL               
   99-03-16  S  ADDED AS A CHIEF CO-SPONSOR              FAWELL                
   99-03-16  S  PLACED CALENDAR ORDER OF FIRST READING   99-03-17              
   99-03-16  S  FIRST READING                                                  
   99-03-16  S  REFERRED TO SENATE RULES COMMITTEE       RULES                 
   99-03-17  S  ADDED AS A CO-SPONSOR                    WALSH,L               
   99-03-17  S  ADDED AS A CO-SPONSOR                    NOLAND                
   99-03-17  S  ADDED AS A CO-SPONSOR                    LINK                  
   99-03-18  S  ADDED AS A CHIEF CO-SPONSOR              SHADID                
   99-03-18  S  ADDED AS A CO-SPONSOR                    DEL VALLE             
   99-03-22  S  ADDED AS A CO-SPONSOR                    BOWLES                
   99-03-23  S  ADDED AS A CO-SPONSOR                    SIEBEN                
   99-03-23  S  ADDED AS A CO-SPONSOR                    OBAMA                 
   99-03-23  S  ADDED AS A CO-SPONSOR                    REA                   
   99-03-23  S  ADDED AS A CO-SPONSOR                    SMITH                 
   99-04-14  S  ADDED AS A CO-SPONSOR                    MUNOZ                 
   99-04-14  S  SPONSOR REMOVED                          KARPIEL               
   99-04-15  S       ASSIGNED TO COMMITTEE               PUBLIC HEALTH         
   99-04-15  S  SPONSOR REMOVED                          MUNOZ                 
   99-04-15  S  SPONSOR REMOVED                          REA                   
   99-04-15  S  SPONSOR REMOVED                          BOWLES                
   99-04-16  S  SPONSOR REMOVED                          OBAMA                 
   99-04-16  S  SPONSOR REMOVED                          SMITH                 
   99-04-27  S       DO PASS                             011-000-000   SPBH    
   99-04-27  S  PLACED ON CALENDAR ORDER OF 2ND READING  99-04-28              
   99-04-28  S  SECOND READING                                                 
   99-04-28  S  PLACED ON CALENDAR ORDER OF 3RD READING  99-04-29              
   99-05-05  S  ADDED AS A CHIEF CO-SPONSOR              MUNOZ                 
   99-05-06  S  THIRD READING - PASSED                   045-012-001           
   99-05-06  H  PASSED BOTH HOUSES                                             
   99-06-04  H  SENT TO THE GOVERNOR                                           
   99-08-02  H  GOVERNOR AMENDATORY VETO                                       
   99-08-02  H  PLACED CALENDAR AMENDATORY VETO          NOVEMBER 16, 1999     
   99-11-16  H  MOTION FILED OVERRIDE AMENDATORY VETO    #1/O'BRIEN            
   99-11-16  H  PLACED CALENDAR AMENDATORY VETO                                
   99-11-18  H  BILL DEAD-AMENDATORY VETO                                      

   END OF INQUIRY 



 Full Text  Bill Summary